BioSpace News Archive

Business

Biotech Companies Team Up to Design New Proteins with ML

Arzeda, Cyrus Biotechnology and Outpace Bio, are teaming up to use machine learning and optimize protein folding and design efforts.

June 28, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Business

Astellas and Sutro Unite to Overcome Checkpoint Inhibitor Limitations with iADCs

Astellas Pharma and Sutro Biopharma inked a global collaboration and licensing deal to work to discover and develop novel immunostimulatory antibody-drug conjugates.

June 28, 2022
·
3 min read
·
Mark Terry
Business

Pfizer, Roivant Unveil Priovant with High Potential TYK2/JAK1 Inhibitor

Pfizer and Roivant unveiled Priovant Therapeutics to develop and market new therapies for a wide range of autoimmune diseases with high mortality and morbidity rates.

June 28, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Ascletis Embarks on Mid-stage Study of Potentially Functional Cure for HIV

Ascletis has commenced its Phase II trial in China for its candidate drug ASC22 alongside anti-retroviral therapy for the functional cure and immune restoration of HIV-1 infection.

June 28, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Beyond Increments: Black Perspectives on Representation in the Life Sciences

BioSpace spoke with several Black individuals working within the life sciences to get their thoughts on the current representative disconnect and what they believe can be done to fix it.

June 28, 2022
·
10 min read
·
Heather McKenzie
Genetown

BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression

BrainsWay Ltd. announced that, for the first time, the Israeli Ministry of Health has approved coverage applicable to its Deep TMS™ system for the treatment of depression.

June 28, 2022
·
5 min read
Business

Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic

The OncoSignature ® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers.

June 28, 2022
·
6 min read
Business

ProSomnus® to Open New Global Headquarters and Manufacturing Center of Excellence, Increasing Manufacturing Capacity and Efficiency

ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea, announced plans for a new 32,219-square-foot facility in Pleasanton, California, USA.

June 28, 2022
·
10 min read
Araris Biotech AG to Present at the H.C. Wainwright Preclinical Cancer Drug Discovery Virtual Conference

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the company will be presenting at the H.C. Wainwright Preclinical Cancer Drug Discovery: Emerging Targets and Modalities virtual conference on June 29, 2022.

June 28, 2022
·
1 min read
Drug Development

Panbela Announces Publication of Preclinical Data Titled: Expanded Potential of the Polyamine Analogue SBP-101 (Diethyl Dihydroxyhomospermine) as a Modulator of Polyamine Metabolism and Cancer Therapeutic

Panbela Therapeutics, Inc today announced the publication of preclinical data from studies of SBP-101 that demonstrated a 42% increase in median survival in a mouse model of VDID8+ ovarian cancer.

June 28, 2022
·
7 min read